Investor FAQs


SIGA is a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens.

The Company's common stock trades under the stock symbol SIGA.

SIGA's administrative offices are located at 660 Madison Avenue Suite 1700, New York, NY 10065. Additional facilities are located in Corvallis, Oregon.

Shares of the Company's common stock can be bought or sold like any other publicly traded stock.

The Company does not offer a direct share purchase plan.

The Company does not currently issue dividends or have a DRIP program.

American Stock Transfer & Trust Company, which may be reached at (718) 921-8293.

The documents that SIGA files with the SEC can be reviewed or downloaded at no charge from our website (see "Financial Information" in the Investor Relations section of http://www.siga.com). The documents can also be obtained at no charge from the SEC website, http://www.sec.gov.

Any investor questions can be directed to the following individuals at KCSA Strategic Communications:

Todd Fromer, tfromer@kcsa.com
Phone #: 212-682-6300

 

The Company's annual report and other financial data can be obtained by contacting KCSA Strategic Communications at 212.682.6300 or by going to The Public Register.

December 31st

Please submit your question using the form below. * Required fields

 
 
 
 
 
 
This helps SIGA prevent automated submissions.